News
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
3h
Everyday Health on MSNNew Daily GLP-1 Weight Loss Pill Gets One Step CloserPeople with type 2 diabetes taking the highest dose of Eli Lilly’s experimental drug orfoglipron lowered their blood sugar and lost 16 pounds on average after 40 weeks.
Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in patients ...
The Health Wagon, in collaboration with the School of Health Sciences at Emory & Henry University and the Mel Leaman Free Clinic will host a two-day free community health fair aimed at providing ...
Fractal Forest Methylene Blue is used to support mitochondrial health, boost ATP production, reduce oxidative stress, and ...
9h
Medpage Today on MSNOral and Injectable Naltrexone Similarly Effective for Alcohol Use DisorderDaily oral and monthly extended-release injectable naltrexone were similarly effective at reducing heavy drinking days in ...
Qure's AMT-130 gene therapy for Huntington’s Disease shows promising trial data. Check out my recommendation for QURE stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results